Madrigal Pharmaceuticals, Inc. · NASDAQ:MDGL
Janus Henderson Group PLC reported a 8.80% stake in Madrigal Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Janus Henderson Group PLC reported a 8.80% stake in Madrigal Pharmaceuticals, Inc., 2,018,647 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 8.80%
- Shares
- 2,018,647
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 8.80% | 2,018,647 |
Source
Related
- Madrigal Pharmaceuticals, Inc.
- Janus Henderson Group PLC
- Madrigal Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Feb 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Nov 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · May 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Feb 14, 2025
- Form 4 · Sibold William John · Sep 11, 2026
- Form 4 · Kelley Shannon T · Aug 20, 2026
- Form 4 · Reed John C · Aug 18, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Sibold William John · Jul 20, 2026